Why the study?
Are hyponatremia and hypernatremia associated with increased all-cause and cause-specific mortality in patients with Stage 3 and 4 CKD?
Cohort (n=45,333)
Are hyponatremia and hypernatremia associated with increased all-cause and cause-specific mortality in patients with Stage 3 and 4 CKD?
Answers are grounded in this paper and cite their sources.
In patients with Stage 3 and 4 CKD, hyponatremia is associated with increased risk of cardiovascular, malignancy, and other deaths, whereas hypernatremia is associated only with non-cardiovascular/non-malignancy deaths.
BACKGROUND: Hyponatremia and hypernatremia are associated with death in the general population and those with chronic kidney disease (CKD). We studied the associations between dysnatremias, all-cause mortality and causes of death in a large cohort of Stage 3 and 4 CKD patients. METHODS: We included 45 333 patients with Stage 3 and 4 CKDs followed in a large healthcare system. Associations between hyponatremia (<136 mmol/L) and hypernatremia (>145), and all-cause mortality and causes of death (cardiovascular, malignancy related and non-cardiovascular/non-malignancy related) were studied using Cox proportional hazards and competing risk models. RESULTS: Dysnatremias were found in 9.2% of the study population. In separate multivariable Cox proportional hazards models using baseline serum sodium levels and time-dependent repeated measures, both hyponatremia and hypernatremia were associated with all-cause mortality. In the competing risk analyses, hyponatremia was significantly associated with increased risk for various cause-specific mortality categories [cardiovascular (hazard ratio, HR 1.16, 95% confidence interval, CI: 1.04, 1.30), malignancy related (HR 1.48, 95% CI: 1.33, 1.65) and non-cardiovascular/non-malignancy deaths (HR 1.25, 95% CI: 1.13, 1.39)], while hypernatremia was significantly associated with higher non-cardiovascular/non-malignancy mortality only (HR 1.36, 95% CI: 1.08, 1.72). CONCLUSIONS: In those with CKD, hyponatremia was associated with all-cause mortality, cardiovascular, malignancy and non-cardiovascular/non-malignancy-related deaths. Hypernatremia was associated with all-cause and non-cardiovascular/non-malignancy-related deaths. Further studies are needed to elucidate the mechanisms of differences in cause-specific death among CKD patients with hyponatremia and hypernatremia.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2016) conducted a cohort in Stage 3 and 4 chronic kidney disease (n=45,333). Hyponatremia and hypernatremia was evaluated on Cardiovascular mortality (associated with hyponatremia) (HR 1.16, 95% CI 1.04-1.30).
Synapse has enriched 10 related papers. Consider them for comparative context: